/Companies

Teal

San Francisco, US · Founded 2020 · 39 employees on LinkedIn · 19 known investors

Find your way into Teal

Each arrow is one introduction. Sign up to fill in the first one.

2,031 people can intro you to Kara

Ask Dain F. DeGroff to introduce you to Kara Egan

You →Dain · together at Stitch Labs →Kara

Sign up to find every way you can get introduced to Teal

  • Your email: who you already know at Teal, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Teal team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Teal provides telehealth healthcare services for people assigned female at birth, offering virtual care without traditional in-office procedures. The company focuses on accessible, judgment-free healthcare across diverse demographic groups.

Also known as getteal.com · Teal · Teal Health

Founders & leadership

Teal was founded in 2020 by Kara Egan.

KEKara Egan
Kara EganFounder · Chief Executive OfficerAdvisor
AT
Avnesh ThakorNamed on SEC filing
JDJoseph DeSimone
Joseph DeSimoneNamed on SEC filing
MB
Matthew BettonvilleNamed on SEC filing
KT
Kathryn Taylor ReddyNamed on SEC filing
SRSarah Rose
Sarah RoseNamed on SEC filing

Board

NJNicole Johnson
Nicole JohnsonBoard directorPartner at Forerunner Ventures

Investors · 19

Also in the syndicate · 5

CityLight CapitalleadEmerson CollectiveleadFlybridgeleadForerunnerleadLabcorp

Funding

SEC filings, press & company announcements

$52.2M disclosed across 3 of 6 rounds · 2020–2026

▶$21.3MraisedAug 2026 · 40 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Kara EganExecutive Officer, Director
  • Avnesh ThakorDirector
  • Joseph DeSimoneDirector
  • Matthew BettonvilleDirector
  • Nicole JohnsonDirector
  • Kathryn Taylor ReddyDirector
  • Sarah RoseExecutive Officer
Offering amount
$23M
Amount sold
$21.3M
First sale
Aug 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.5MraisedJan 2025 · 74 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Avnesh ThakorDirector
  • Joseph DeSimoneDirector
  • Kara EganExecutive Officer, Director
  • Matthew BettonvilleDirector
  • Nicole JohnsonDirector
Offering amount
$23.5M
Amount sold
$23.5M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Teal Health (getteal.com) offers at-home cervical cancer screening in the United States built around the Teal Wand, a self-collection device for a vaginal sample that is mailed to a lab and tested on the Roche cobas Primary HPV assay, the same FDA-approved HPV test used in clinics. The service is delivered as a bundled telehealth product: a patient completes an eligibility form, has a roughly 10-minute virtual intro visit with a Teal Medical OBGYN or nurse practitioner who prescribes the kit, receives the kit in three to five days, self-collects in about five minutes, mails the sample via a pre-paid USPS return mailer, and receives provider-reviewed results in a secure portal in about one week. If results are abnormal (HPV positive), a Teal Medical provider discusses next steps virtually and helps coordinate in-person referral care.

The company positions the product for people aged 25-65 with a cervix, in line with American Cancer Society screening guidelines, and excludes certain groups (for example those who are pregnant, immunocompromised, HIV-positive, with a history of reproductive cancer, DES exposure, or recent cervical precancer treatment). Marketing segments emphasized on the site include first-time screeners, people with a history of trauma or vaginismus, people in menopause, and varying body types. Teal states its at-home screening interval is every three years. The company also maintains a research program, publishing the SELF-CERV validation study in JAMA Network Open (May 2025) and presenting at conferences on screening among LGBQ+ and rural populations [0][2][3][4][5].

Compiled by commissioned research from 13 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average customer rating on company websiteJan 20265 out of 5
Clinical trial oversubscriptionNov 202520%
Clinical trial participants preferring the Teal Wand to in-clinic screeningJan 202594%
Detection accuracy for cervical precancer vs. clinician-collected samplesMay 202596%
Relative sensitivity for detecting CIN2+ vs. clinician collectionMay 20251
SELF-CERV clinical trial participantsJan 2025600 participants
SELF-CERV clinical trial sitesJan 202516 sites
Study acceptance rate among women asked to participateNov 202580%
Total disclosed funding raised to dateJan 2025$23M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 5

Companies working in the same space as Teal.

Timeline · 11

launches, deals, and filings
Jul 2026
Collaboration with UC Davis Health on at-home cervical cancer screening

Teal Health announced work with UC Davis Health to advance at-home cervical cancer screening within health systems.

source ↗

Jan 2026
Collaboration with WashU Medicine to expand cervical cancer screening

source ↗

Jun 2025
Teal Wand becomes available in California

Teal Health planned to make the Teal Wand available in California first, starting in June 2025, ordered online and paired with a telehealth visit.

source ↗

May 2025
FDA authorizes the Teal Wand for at-home cervical cancer screening

The FDA granted marketing authorization for Teal Health's Teal Wand self-collection device, the first at-home cervical cancer screening test in the U.S. The device had previously received FDA Breakthrough Device designation.

source ↗

May 2025
Clinical validation study published in JAMA Network Open

Fitzpatrick MB, Behrens CM, Hibler K, et al. 'Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use.' JAMA Network Open. 2025;8(5):e2511081.

source ↗

Jan 2025
Teal Health closes additional $10M in seed funding

Teal Health announced an additional $10 million in seed funding led by Emerson Collective and Forerunner, with continued support from Serena Ventures and Metrodora and new investor Labcorp, bringing total funding to $23 million to date.

$10M source ↗

Jan 2025
Fast Company Next Big Thing in Tech (Healthcare)

source ↗

Jan 2025
Inc. Magazine Best in Business, Health Services

source ↗

Jan 2025
TIME Magazine Best Invention for the Teal Wand

source ↗

Jan 2025
Business Insider Most Promising Healthcare Startups

source ↗

Jan 2025
$1.68M SBIR grant from the National Cancer Institute

Teal Health received a $1.68 million Small Business Innovation Research grant from the National Cancer Institute, cited as a recent achievement at the time of its January 2025 seed announcement.

$1.7M source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

▸Research sources · 13

primary sources listed

13 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Teal do?
Teal Health sells an FDA-authorized at-home self-collection kit for cervical cancer screening paired with telehealth OBGYN care.
Who founded Teal?
Teal was founded by Kara Egan in 2020.
Who are Teal's investors?
Teal's investors include .406 Ventures, Aventurine Partners, Black Jays Ventures, Felicis Ventures, Forerunner Ventures, Halogen Ventures Management Company Llc, Metrodora Ventures, Nextblue and 6 more.
How much funding has Teal raised?
Teal has disclosed $52.2M raised across 3 of its 6 known rounds.
Where is Teal headquartered?
Teal is headquartered in San Francisco, US.